-- 根據週二提交給香港交易所的文件,利記控股(HKG:0637)預計截至3月31日止年度的應占利潤為460萬港元至690萬港元,而上年同期則虧損3610萬港元。 這家金屬製品貿易公司將獲利預期歸功於毛利成長、穩健的供應鏈管理以及土地徵用補償。
Related Articles
Sunita Tools' US Unit Sets Up Office in Chicago
Sunita Tools' (BOM:544001) U.S.-based subsidiary Sunita Defence Inc. has established a full-time office in Chicago, according to an Indian bourse filing on Tuesday.The subsidiary was created to bid for and supply defense products in the U.S. market and explore acquisition opportunities in the defense, aerospace and engineering space.
Zuoli Kechuang Micro-finance Changes Name to Zuoli Kechuang
Zuoli Kechuang Micro-finance Company changed its English name to Zuoli Kechuang Company Limited (HKG:6866), alongside a change in its Chinese name, according to a Tuesday Hong Kong bourse filing.The name change came about following the relevant regulatory and shareholder approvals.The financial services company's English stock short name will be changed to ZUOLI KECHUANG from ZUOLI M-FIN effective 9:00 am on May 8.
Research Alert: Adm: Solid Q1 Results; Guidance Raised As Expected On Biofuel Policy Clarity
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Archer-Daniels-Midland (ADM) delivered solid Q1 2026 results, with adjusted EPS of $0.71 (+1% Y/Y) beating consensus by $0.05. The company raised full-year 2026 guidance to $4.15-$4.70 (consensus: $4.23) from $3.60-$4.25, supported by the March 2026 Renewable Fuel Standard finalization, which provides crucial policy clarity. This regulatory certainty supports the biofuels sector and strengthens ADM's investment thesis. Carbohydrate Solutions was the standout performer, with operating profit surging 48% to $356M as ethanol operations capitalized on strengthening margins from the improved policy environment. While AS&O faced headwinds with operating profit declining 34% to $273M due to mark-to-market impacts, its underlying operational performance showed resilience. The Nutrition segment continued its recovery trajectory with 42% growth in operating profit to $135M. We believe the combination of regulatory clarity and strong operational execution positions ADM well for improved earnings performance through 2026.